Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-04 11:42 am Sale | 13G | SEATTLE GENETICS INC SGEN | WELLINGTON MANAGEMENT GROUP LLP | 5,662,159 3.14% | -4,645,179 (-45.07%) | View |
| 2021-02-01 08:17 am Purchase | 13G | SEAGEN INC SGEN | BlackRock Inc. BLK | 12,520,079 6.9% | 12,520,079 (New Position) | View |
| 2020-05-19 5:26 pm Sale | 13D | SEATTLE GENETICS INC SGEN | BAKER BROS. ADVISORS LP | 47,615,277 27.5% | -1,750,000 (-3.55%) | View |
| 2020-05-08 5:23 pm Sale | 13D | SEATTLE GENETICS INC SGEN | BAKER BROS. ADVISORS LP | 49,365,277 28.5% | -1,058,316 (-2.10%) | View |
| 2020-04-24 4:32 pm Sale | 13D | SEATTLE GENETICS INC SGEN | BAKER BROS. ADVISORS LP | 50,423,593 29.2% | -881,639 (-1.72%) | View |
| 2020-04-24 3:37 pm Sale | 13G | SEATTLE GENETICS INC SGEN | PRIMECAP MANAGEMENT CO | 7,476,972 4.34% | -3,474,745 (-31.73%) | View |
| 2020-02-14 1:30 pm Purchase | 13G | SEATTLE GENETICS INC SGEN | PRICE T ROWE ASSOCIATES INC | 9,828,030 5.7% | 1,753,290 (+21.71%) | View |
| 2020-02-14 12:07 pm Purchase | 13G | SEATTLE GENETICS INC SGEN | Capital International Investors | 20,996,099 12.2% | 4,618,918 (+28.20%) | View |
| 2020-02-12 2:52 pm Sale | 13G | SEATTLE GENETICS INC SGEN | PRIMECAP MANAGEMENT CO | 10,951,717 6.39% | -3,189,558 (-22.55%) | View |
| 2020-02-12 11:13 am Purchase | 13G | SEATTLE GENETICS INC SGEN | VANGUARD GROUP INC | 10,916,170 6.36% | 1,671,222 (+18.08%) | View |
| 2020-02-07 08:45 am Purchase | 13G | SEATTLE GENETICS INC SGEN | BlackRock Inc. BLK | 9,837,619 5.7% | 1,621,852 (+19.74%) | View |
| 2020-01-27 3:56 pm Sale | 13G | SEATTLE GENETICS INC SGEN | WELLINGTON MANAGEMENT GROUP LLP | 10,307,338 6.01% | -4,832,098 (-31.92%) | View |
| 2019-08-09 3:04 pm Sale | 13G | SEATTLE GENETICS INC SGEN | BlackRock Inc. BLK | 8,215,767 4.9% | -889,214 (-9.77%) | View |
| 2019-05-10 1:22 pm Purchase | 13G | SEATTLE GENETICS INC SGEN | Capital International Investors | 16,377,181 10.2% | 1,680,229 (+11.43%) | View |